Here Are Some Essential Facts About Perrigo Company (PRGO)

Mid-cap health care company Perrigo Company has moved 2.9% this afternoon, reaching $30.07 per share. In contrast, the average analyst target price for the stock is $44.67.

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. The company is based in Ireland. Perrigo Company currently returns an annual dividend yield of 3.7%.

Make Sure to Consider the Following Before Buying Perrigo Company:

  • Perrigo Company has moved -4.0% over the last year.

  • PRGO has a forward P/E ratio of 9.8 based on its EPS guidance of 3.06.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of -20.3%.

  • The company has a price to earnings growth (PEG) ratio of 1.14.

  • Its Price to Book (P/B) ratio is 0.86

Perrigo Company Has None

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k)
2023 317,400 90,900 226,500
2022 307,300 96,400 210,900
2021 156,300 152,100 4,200
2020 636,200 170,400 465,800
2019 387,800 137,700 250,100
2018 593,000 102,600 490,400


The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.